Thermally regulated transdermal drug delivery system
US12397141B2 · kind B2 · utility
0Cited by
280References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 15, 2019 |
| Grant date | Aug 26, 2025 |
| Priority date | — |
| Expiry date | Sep 13, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2205/8206
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are drug and other active agent transdermal delivery systems and devices to deliver active agents to skin or mucosa of a subject, and methods of delivering such active agents. In particular, systems, methods, and devices are described that control the concentration and timing of active agent delivery. Such systems or devices may include a transdermal membrane and a temperature control element for heating and/or cooling a portion of the transdermal delivery system to provide pulsatile active agent delivery through the transdermal membrane.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.